Diagnosis of tumor in the nasal cavity and paranasal sinuses with [ 11C]choline PET: Comparative study with 2-[ 18F]fluoro-2-deoxy-D-glucose (FDG) PET

Annals of Nuclear Medicine

Volumn 18, Issue 1, 2004, Pages 29-34

  Ninomiya, Hiroshi ^a   Oriuchi, Noboru ^a   Kahn, Nasim ^a   Higuchi, Tetsuya ^a   Endo, Keigo ^a   Takahashi, Katsumasa ^a   Chikamatsu, Kazuaki ^a   Kamada, Hideo ^a   Furuya, Nobuhiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11C choline; FDG; Head and neck tumor; Nasal cavity; Paranasal sinus

Indexed keywords

CARBON 11; CHOLINE; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NOSE CAVITY; NOSE TUMOR; PARANASAL SINUS; PARANASAL SINUS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STANDARDIZATION; STATISTICAL ANALYSIS; TUMOR DIAGNOSIS;

EID: 1842685828     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985611     Document Type: Article

References (20)

1. Rege S, Maas A, Chaaiken L, Hoh CK, Choi Y, Lufkin R, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994; 73: 3047-3058.
2. McGuirt WF, Graven K, Williams III DW, Keyes JW Jr, Watson N, Cappellari JO, et al. PET scanning in head and neck oncology: a review. Head Neck 1998; 20: 208-215.
3. Halfpenny W, Hain SF, Biassoni L, Maisey MN, Sherman JA, McGurk M. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002; 86: 512-516.
4. Graven KM, William III DW, Keyes JW, McGuirt WF, Watson NE Jr, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997; 3: 353-357.
5. Terhaad CH, Bongers V, van Rijk PP, Hordijk GJ. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001; 23: 933-941.
6. Graven KM, Williams III DW, Keyes JW, McGuirt WF, Watson NE Jr, Randall ME, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74: 1355-1359.
7. 18F-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-1980.
8. Haberkoorn U, Strauss LG, Reisser CH, Haag D, Dimitrakopoulou A, Ziegler S, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: Relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32: 1548-1555.
9. Shonoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: Detection with C-11 choline PET. Radiology 1997; 202: 497-503.
10. 18F-fluorodeoxyglucose. Cancer 1999; 86: 1638-1648.
11. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998; 39: 990-995.
12. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001; 28: 1664-1670.
13. 11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999; 50: 531-533.
14. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
15. Meikle SR, Bailey DL, Hooper PK, Eberl S, Hutton BF, Jones WF, et al. Simultaneous emission and transmission measurement for attenuation correction in whole-body PET. J Nucl Med 1995; 36: 1680-1688.
16. 18F]fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002; 20: 1398-1404.
17. Aiken NR, Gillies RJ. Phosphomonoester metabolism as a function of cell proliferative status and exogenous precursors. Anticancer Res 1996; 16: 1393-1398.
18. Warden CH, Friedkin M. Regulation of choline kinase activity and phosphatidylcholine biosynthesis by mitogenic growth factors in 3T3 fibroblasts. J Biol Chem 1985; 260: 6006-6011.
19. Macara IG. Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown. Mol Cell Biol 1989; 9: 325-328.
20. Teegarden D, Taparowwsky EJ, Kent C. Altered phosphatidylcholine metabolism in C3H10T [1/2] cells transfected with the Harvey-ras oncogene. J Biol Chem 1990; 265: 6042-6047.